Rapport Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 3.00 M | $91.08 M | 23.94% | 7.91% |
| BLACKROCK, INC. | 02/12/2026 | 2.43 M | $73.78 M | 55.09% | 6.41% |
| VANGUARD GROUP INC | 01/29/2026 | 1.82 M | $55.15 M | 11.76% | 4.79% |
| JOHNSON & JOHNSON | 03/18/2026 | 1.78 M | $54.14 M | 0.00% | 4.70% |
| BAKER BROS. ADVISORS LP | 02/17/2026 | 1.55 M | $46.94 M | 0.00% | 4.08% |
| VESTAL POINT CAPITAL, LP | 02/17/2026 | 1.11 M | $33.68 M | 16.84% | 2.93% |
| POLAR CAPITAL HOLDINGS PLC | 02/17/2026 | 1.00 M | $30.48 M | 7.01% | 2.65% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 881.61 K | $26.75 M | -20.03% | 2.32% |
| ALLIANCEBERNSTEIN L.P. | 02/17/2026 | 788.41 K | $23.92 M | -7.86% | 2.08% |
| STATE STREET CORP | 02/13/2026 | 714.82 K | $21.69 M | 92.35% | 1.88% |
| TRV GP V, LLC | 02/13/2026 | 7.14 M | $216.48 M | 0.00% | 1.88% |
| FMR LLC | 02/17/2026 | 7.11 M | $215.77 M | 2.82% | 1.87% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 694.73 K | $21.08 M | 30.25% | 1.83% |
| PERCEPTIVE ADVISORS LLC | 02/17/2026 | 673.92 K | $20.45 M | 66.84% | 1.78% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/19/2026 | 619.03 K | $18.78 M | -12.51% | 1.63% |
| ARCH VENTURE MANAGEMENT, LLC | 02/17/2026 | 3.73 M | $113.13 M | 0.00% | 0.98% |
| CAPITAL INTERNATIONAL INVESTORS | 02/11/2026 | 3.40 M | $103.23 M | 0.00% | 0.90% |
| CORMORANT ASSET MANAGEMENT, LP | 02/17/2026 | 3.03 M | $91.85 M | -5.17% | 0.80% |
| INVESCO LTD. | 02/19/2026 | 267.12 K | $8.10 M | 69.08% | 0.70% |
| PRUDENTIAL FINANCIAL INC | 02/13/2026 | 254.97 K | $7.74 M | 100.00% | 0.67% |
| BURKEHILL GLOBAL MANAGEMENT, LP | 02/17/2026 | 250.00 K | $7.59 M | 0.00% | 0.66% |
| UBS GROUP AG | 01/29/2026 | 226.36 K | $6.87 M | -59.44% | 0.60% |
| MORGAN STANLEY | 02/13/2026 | 210.33 K | $6.38 M | -23.40% | 0.55% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 201.83 K | $6.12 M | 30.91% | 0.53% |
| SOFINNOVA INVESTMENTS, INC. | 02/13/2026 | 1.90 M | $57.78 M | -2.22% | 0.50% |
| SIO CAPITAL MANAGEMENT, LLC | 02/17/2026 | 185.27 K | $5.62 M | 0.00% | 0.49% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 150.00 K | $4.55 M | -66.67% | 0.40% |
| ARTIA GLOBAL PARTNERS LP | 02/17/2026 | 138.51 K | $4.20 M | 114.38% | 0.37% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 118.81 K | $3.60 M | 236.58% | 0.31% |
| TRV GP VI, LLC | 02/13/2026 | 969.22 K | $29.41 M | 0.00% | 0.26% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/13/2026 | 952.37 K | $28.89 M | 6.74% | 0.25% |
| NUVEEN, LLC | 02/12/2026 | 70.95 K | $2.15 M | 224.35% | 0.19% |
| SIREN, L.L.C. | 02/13/2026 | 708.47 K | $21.49 M | -32.75% | 0.19% |
| TREXQUANT INVESTMENT LP | 02/17/2026 | 62.98 K | $1.91 M | 206.93% | 0.17% |
| EVERSEPT PARTNERS, LP | 02/17/2026 | 59.23 K | $1.80 M | -58.74% | 0.16% |
| BARCLAYS PLC | 02/13/2026 | 52.48 K | $1.59 M | 96.46% | 0.14% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 50.62 K | $1.54 M | 135.44% | 0.13% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/17/2026 | 34.65 K | $1.05 M | 100.00% | 0.09% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 34.55 K | $1.05 M | -40.49% | 0.09% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 32.11 K | $974.19 K | 138.52% | 0.08% |
| RHUMBLINE ADVISERS | 02/13/2026 | 30.73 K | $932.22 K | 26.52% | 0.08% |
| JANE STREET GROUP, LLC | 02/12/2026 | 26.00 K | $788.84 K | -86.03% | 0.07% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 247.32 K | $7.50 M | 100.00% | 0.07% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 244.39 K | $7.41 M | 20.72% | 0.06% |
| NORTHERN TRUST CORP | 02/17/2026 | 220.82 K | $6.70 M | 43.52% | 0.06% |
| ENSIGN PEAK ADVISORS, INC | 02/12/2026 | 194.20 K | $5.89 M | 0.00% | 0.05% |
| KENNEDY CAPITAL MANAGEMENT LLC | 02/13/2026 | 178.74 K | $5.42 M | 100.00% | 0.05% |
| 02/06/2026 | 17.51 K | $531.13 K | 100.00% | 0.05% | |
| CITADEL ADVISORS LLC | 02/17/2026 | 16.90 K | $512.75 K | -51.16% | 0.04% |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 02/17/2026 | 16.78 K | $509.20 K | 100.00% | 0.04% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Rapport Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 167 institutional investors and hedge funds held shares of Rapport Therapeutics Inc.. The most heavily invested institutionals were:
Candriam S.C.A.: 185,925
UBS Group AG: 151,758
Swedbank AB: 113,200
Bank of New York Mellon Corp: 72,319
Nuveen, LLC: 71,508
Y-Intercept (Hong Kong) Ltd: 35,825
134.68% of Rapport Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 51.30 M shares in the last 24 months. This purchase volume represents approximately $1.57 B in transactions.